Events

Meet the Precision
AQ team at ISPOR 2026

Philadelphia, PA | May 17-20, 2026

Precision AQ is a commercialization partner for biopharma innovators, market access teams, and brand strategists. Working with clients from all 30 of the world’s top pharma companies, we specialize in turning data chaos into commercial clarity.

Schedule time to meet our HEOR & Access Strategy team at ISPOR 2026.

Whether it’s building the right evidence or refining your value story, we’re here to simplify the journey from development to patient care – so your therapies can reach the patients who need them most.

Complete the form to book a meeting, and we’ll reach out to confirm the details.

book a meeting

Precision AQ's Posters at ISPOR EU 2025

Monday May 18 - Poster Session 1

HPR15: Trends and Postmarketing Outcomes of Accelerated Approvals (AAs) in FDA New Drug Applications and Biologic License Applications (NDAs/BLAs) from 1992-2025

Sarah Ronnebaum, PhD

download

Monday May 18 - Poster Session 2

CO52: Effect of Wound Exudate Severity on Time to Complete Healing in Diabetic Foot Ulcers: A Real-World Longitudinal Analysis (EXACT Study)

David G. M. Armstrong, PhD, MD, Grace Gahlon, PhD, Vladica M. Velickovic, PhD, MD, Yun Han, PhD, Niuosha M. Sanaeifar, PhD, Shelby Corman, PhD, Kenneth Rothman, PhD

Tuesday May 19 - Poster Session 3

HPR81: Breakthrough Therapy (BT) and Fast Track (FT) Designations in New Drug Applications and Biologic License Applications (NDAs/BLAs) to FDA’s Center for Drug Evaluation and Research (CDER), 2013-2025

Sarah Ronnebaum, PhD

download

MSR117: Incorporating Published Subgroup Analyses Into Multilevel Network Meta-Regression via Bayesian Synthetic Likelihood

Harlan Cambell, PhD, Jeroen Jansen, PhD, Paul Gustafson, PhD, Charles Margossian, PhD

download